vancomycin has been researched along with dalbavancin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Judice, JK; Pace, JL | 1 |
Draghi, DC; Goldstein, BP; Hogan, P; Sahm, DF; Sheehan, DJ | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Bell, JM; Biedenbach, DJ; Jones, RN; Sader, HS; Turnidge, JD | 1 |
Bassett, J; Goldstein, BP; Heine, HS; Miller, L; Purcell, BK | 1 |
Akkapeddi, P; Haldar, J; Manjunath, GB; Yarlagadda, V | 1 |
1 review(s) available for vancomycin and dalbavancin
Article | Year |
---|---|
Semi-synthetic glycopeptide antibacterials.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Glycopeptides; Humans | 2003 |
5 other study(ies) available for vancomycin and dalbavancin
Article | Year |
---|---|
Bactericidal activity and resistance development profiling of dalbavancin.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Staphylococcus aureus; Teicoplanin; Vancomycin; Vancomycin Resistance | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
Topics: Anti-Bacterial Agents; Asia; Drug Resistance, Bacterial; Europe; Gram-Positive Bacteria; Humans; Latin America; Microbial Sensitivity Tests; North America; Pacific Ocean; Quality Control; Teicoplanin; Vancomycin | 2009 |
Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax model.
Topics: Administration, Inhalation; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Teicoplanin; Treatment Outcome | 2010 |
Membrane active vancomycin analogues: a strategy to combat bacterial resistance.
Topics: Animals; Bacteremia; Cell Membrane Permeability; Drug Resistance, Bacterial; Enterococcus; Female; HeLa Cells; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Neutropenia; Quaternary Ammonium Compounds; Staphylococcal Infections; Staphylococcus; Structure-Activity Relationship; Triazoles; Vancomycin | 2014 |